Cargando…

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

d-Lysergic Acid Diethylamide (LSD) is known for its hallucinogenic properties and psychotic-like symptoms, especially at high doses. It is indeed used as a pharmacological model of psychosis in preclinical research. The goal of this review was to understand the mechanism of action of psychotic-like...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Gregorio, Danilo, Comai, Stefano, Posa, Luca, Gobbi, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133947/ https://www.ncbi.nlm.nih.gov/pubmed/27886063 http://dx.doi.org/10.3390/ijms17111953

Ejemplares similares

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
por: De Gregorio, Danilo, et al.
Publicado: (2021)

PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors
por: Gregorio, Danilo De, et al.
Publicado: (2016)

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
por: Kanen, Jonathan W., et al.
Publicado: (2023)

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
por: Inserra, Antonio, et al.
Publicado: (2021)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT(2A) and ampa in the medial prefrontal cortex (MPFC)
por: Markopoulos, A., et al.
Publicado: (2021)

Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry
por: Freedman, Daniel X.
Publicado: (1957)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
por: Kopra, Emma I, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
por: Savino, Aurora, et al.
Publicado: (2021)

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
por: Ramaekers, Johannes G, et al.
Publicado: (2020)

Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics
por: Tsochatzis, Emmanouil, et al.
Publicado: (2020)

Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line
por: Jurič, Andreja, et al.
Publicado: (2021)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

Self-inflicted neck wounds under influence of lysergic acid diethylamide: A case report and literature review
por: Le Daré, Brendan, et al.
Publicado: (2020)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
por: Kopra, Emma I, et al.
Publicado: (2023)

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2020)

Optimized Analysis of Ergot Alkaloids in Rye Products by Liquid Chromatography-Fluorescence Detection Applying Lysergic Acid Diethylamide as an Internal Standard
por: Holderied, Iris, et al.
Publicado: (2019)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2022)

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice
por: Elsilä, Lauri V, et al.
Publicado: (2022)

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity
por: Nasretdinov, Azat, et al.
Publicado: (2023)

Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task
por: Elsilä, Lauri V., et al.
Publicado: (2020)

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
por: Ley, Laura, et al.
Publicado: (2023)

Validation of a New Sensitive Method for the Detection and Quantification of R and S-Epimers of Ergot Alkaloids in Canadian Spring Wheat Utilizing Deuterated Lysergic Acid Diethylamide as an Internal Standard
por: Cherewyk, Jensen, et al.
Publicado: (2021)

Valyl: Valerianic Acid Diethylamid
Publicado: (1902)

Reconstituting the complete biosynthesis of D-lysergic acid in yeast
por: Wong, Garrett, et al.
Publicado: (2022)

Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs
por: Tirri, Micaela, et al.
Publicado: (2022)

Melatonin MT(1) and MT(2) Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle
por: López-Canul, Martha, et al.
Publicado: (2019)

Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study
por: Gobbi, Gabriella, et al.
Publicado: (2014)

Methods of Lysergic Acid Synthesis—The Key Ergot Alkaloid
por: Jastrzębski, Michał K., et al.
Publicado: (2022)

Rhodococcus erythropolis MTHt3 biotransforms ergopeptines to lysergic acid
por: Thamhesl, Michaela, et al.
Publicado: (2015)

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
por: De Gregorio, Danilo, et al.
Publicado: (2019)

Construction of an efficient Claviceps paspali cell factory for lysergic acid production
por: Hu, Mingzhe, et al.
Publicado: (2023)

Contribution of a novel gene to lysergic acid amide synthesis in Metarhizium brunneum
por: Britton, Kelcie N., et al.
Publicado: (2022)

Differential Function of Melatonin MT(1) and MT(2) Receptors in REM and NREM Sleep
por: Gobbi, Gabriella, et al.
Publicado: (2019)

Pharmacological Inhibition of LSD1 for Cancer Treatment
por: Yang, Guan-Jun, et al.
Publicado: (2018)

Effects of Chronic Exposure to Low-Dose delta-9-Tetrahydrocannabinol in Adolescence and Adulthood on Serotonin/Norepinephrine Neurotransmission and Emotional Behavior
por: De Gregorio, Danilo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m4badei1ole2dss6tg9jlb2n4r